Key points are not available for this paper at this time.
The national cancer-attributed medical care costs in the United States are substantial and projected to increase dramatically by 2030, due to population changes alone, reflecting the rising burden of cancer care among cancer survivors.
Mariotto et al. (Wed,) studied this question.